News

Read more

TGD001 receives Orphan Drug Designation in Europe

July 29, 2024
Read more

Dr. Anja Harmeier as Supervisory Board Member

September 5, 2023
Read more

Key Appointments Management Team

May 2, 2023
Read more

Appointed – Erik van den Berg as Chair of Board

January 19, 2023
Read more

Appointed – Scientific Advisory Board AIS

September 16, 2022
Read more

Microlyse as treatment for AIS published in Blood journal

August 17, 2022
Read more

Microlyse as treatment for TTP published in Blood journal

February 19, 2022
Read more

TargED raises €39 million in a series A investment round

February 19, 2022
Read more

TargED is granted the NWO Take Off II loan

December 18, 2020
Read more

TargED closes €1.35m seed investment round!

November 30, 2020
Read more

FOUNDED

July 7, 2020